Clinical Trial Update: Comparison Of Molecular Targets In Mild To Severe Asthmatics And Healthy Subjects [Phase 1]

View source ↗

Summary

Phase 1 clinical trial comparing molecular targets in mild-to-severe asthma patients and healthy subjects. The study status is terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Snippet

Sponsor: GlaxoSmithKline | Conditions: Asthma | Phase 1 | Status: TERMINATED